Rheumatology International

, Volume 34, Issue 2, pp 281–282 | Cite as

The lobster sign in SAPHO syndrome: unusually extensive osteitis of the anterior chest wall partially responsive to infliximab

  • Branimir Anić
  • Ivan PadjenEmail author
  • Marko Barešić
  • Stanko Težak
Letter to the Editors


Infliximab Psoriatic Arthritis Hyperostosis Sternoclavicular Joint Elevated Inflammatory Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A (1987) Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 Cases. Rev Rhum Mal Osteoartic 54(3):187–196PubMedGoogle Scholar
  2. 2.
    Benhamou CL, Chamot AM, Kahn MF (1988) Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 6(2):109–112PubMedGoogle Scholar
  3. 3.
    Hayem G (2007) Valuable lessons from SAPHO syndrome. Joint Bone Spine 74(2):123–126PubMedCrossRefGoogle Scholar
  4. 4.
    Moll C, Hernandez MV, Canete JD et al (2008) Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature. Semin Arthritis Rheum 37(5):299–306PubMedCrossRefGoogle Scholar
  5. 5.
    Depasquale R, Kumar N, Lalam RK et al (2012) SAPHO: what radiologists should know. Clin Radiol 67(3):195–206PubMedCrossRefGoogle Scholar
  6. 6.
    Colina M, Govoni M, Orzincolo C, Trotta F (2009) Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 61(6):813–821PubMedCrossRefGoogle Scholar
  7. 7.
    Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P et al (2008) Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 47(8):1160–1167CrossRefGoogle Scholar
  8. 8.
    Massara A, Cavazzini PL, Trotta F (2006) In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) 45(6):730–733CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Branimir Anić
    • 1
  • Ivan Padjen
    • 1
    Email author
  • Marko Barešić
    • 1
  • Stanko Težak
    • 2
  1. 1.Division of Clinical Immunology and Rheumatology, Department of Internal MedicineUniversity of Zagreb School of Medicine, University Hospital Centre ZagrebZagrebCroatia
  2. 2.Clinical Department of Nuclear Medicine and Radiation ProtectionUniversity Hospital Centre ZagrebZagrebCroatia

Personalised recommendations